Thiotepa (Sagent Pharmaceuticals)


Welcome to the PulseAid listing for the Thiotepa drug offered from Sagent Pharmaceuticals. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.




LABELER NAME / MANUFACTURER: Sagent Pharmaceuticals
NON-PROPRIETARY NAME: Thiotepa
SUBSTANCE NAME: THIOTEPA
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: INTRACAVITARY; INTRAVENOUS; INTRAVESICAL
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-08-15
END MARKETING DATE: 0000-00-00


Thiotepa HUMAN PRESCRIPTION DRUG Details:

Item DescriptionThiotepa from Sagent Pharmaceuticals
LABELER NAME: Sagent Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 15(mg/1.5mL)
START MARKETING DATE: 2017-08-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 25021-246_a3ae11de-edf2-4750-bb92-efd6ae81af70
PRODUCT NDC: 25021-246
APPLICATION NUMBER: ANDA209150

Other THIOTEPA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ADIENNE SATEPADINA
Amneal Biosciences LLCTEPADINA
Sagent PharmaceuticalsThiotepa
West-Ward Pharmaceuticals CorpThiotepa